Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Completed · Phase 3 · Has a placebo group
Conditions studied: Ocular Hypertension, Open-angle Glaucoma
In brief
To evaluate the ocular hypotensive efficacy and ocular and systemic safety of AR-13324 Ophthalmic Solution, 0.02% compared to the active comparator Timolol maleate Ophthalmic Solution, 0.5%
Key facts
- Study ID
- NCT02207491
- Run by
- Aerie Pharmaceuticals
- People needed
- 411
- Starts
- 2014-07-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2018-04-13
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Aerie Pharmaceuticals — Bedminster, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.